Ultomiris Drug Market
完整報告名稱與涵蓋範圍
Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (PNH, Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder), By End Use, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034.
報告摘要
The Ultomiris Drug Market on a global scale was estimated at USD 3.9 Bn in 2024 and is expected to attain USD 44.3 Bn by 2034, with a projected CAGR of 27.7% between 2025 and 2034.
The Ultomiris Drug sector involves uncommon. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is driven by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Ultomiris Drug Market Snapshot
Chapter 4. Global Ultomiris Drug Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Ultomiris Drug Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Ultomiris Drug Market Industry Trends
Chapter 5. Ultomiris Drug Market Segmentation 1: By Indication, Estimates & Trend Analysis
5.1. Market Share by Indication, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:
5.2.1. Paroxysmal Nocturnal Hemoglobinuria (PNH)
5.2.2. Atypical Hemolytic Uremic Syndrome (aHUS)
5.2.3. Generalized Myasthenia Gravis (gMG)
5.2.4. Neuromyelitis Optica Spectrum Disorder (NMOSD)
Chapter 6. Ultomiris Drug Market Segmentation 2: By End Use, Estimates & Trend Analysis
6.1. Market Share by End Use, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Use:
6.2.1. Adult
6.2.2. Pediatric
Chapter 7. Ultomiris Drug Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share by Distribution Channel, 2024 & 2034
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Ultomiris Drug Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Ultomiris Drug Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Indication, 2021-2034
8.2.3. North America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.2.4. North America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Distribution Channel, 2021-2034
8.3. Europe
8.3.1. Europe Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Indication, 2021-2034
8.3.3. Europe Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.3.4. Europe Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Distribution Channel, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Indication, 2021-2034
8.4.3. Asia Pacific Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.4.4. Asia Pacific Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Distribution Channel, 2021-2034
8.5. Latin America
8.5.1. Latin America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Indication, 2021-2034
8.5.3. Latin America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.5.4. Latin America Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Distribution Channel, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Indication, 2021-2034
8.6.3. Middle East & Africa Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.6.4. Middle East & Africa Ultomiris Drug Market Revenue (US$ Mn) Estimates and Forecasts by Distribution Channel, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AstraZeneca
9.2.1.1. Business Overview
9.2.1.2. Key Indication/Service
9.2.1.3. Financial PerEnd Useance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Other Leading Companies
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們